# FDA recall D-1473-2022

> **Teva Pharmaceuticals USA Inc** · Class II · drug recall initiated 2022-08-23.

## Product

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

## Reason for recall

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-1473-2022
- **Recalling firm:** Teva Pharmaceuticals USA Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-08-23
- **Report date:** 2022-09-07
- **Termination date:** 2023-09-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1473-2022

## Citation

> AI Analytics. FDA recall D-1473-2022. Retrieved 2026-06-10 from https://api.ai-analytics.org/recall/D-1473-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*